Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
FairJourney Biologics
FairJourney Biologics
Activities:
Research & Development
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Finance
FairJourney Biologics moves to purpose-built research facility
The centre in Porto, Portugal is larger than the company's previous premises, and is hoped to support its expansion plans
Research & Development
Hubrecht Institute licenses reagent antibodies for cancer research
The Clevers group dedicates its activity to the study of the molecular mechanisms of tissue development and cancer of various organs using organoids made from adult Lgr5 stem cells
Finance
FairJourney enters antibody discovery agreement with Pandion
Pandion focuses on the development of modular therapeutics using its Talon (Therapeutic Autoimmune reguLatOry proteiN) drug design and discovery platform
Research & Development
Abzena and FairJourney Biologics link up to provide full antibody services from discovery to manufacture
Both firms offer protein engineering services to provide antibodies tailored to the desired format and humanised
Subscribe now